The regulation of iron metabolism in the mononuclear phagocyte system

Expert Review of Hematology

Volumn 6, Issue 4, 2013, Pages 411-418

  Kong, Wei Na ^a,b   Lei, Yu Hua ^a   Chang, Yan Zhong ^a  

^a HEBEI NORMAL UNIVERSITY   (China)

^b HEBEI CHEMICAL AND PHARMACEUTICAL COLLEGE   (China)

Author keywords

divalent metal transporter 1; ferroportin 1; hepcidin; mononuclear phagocyte system; Transferrin receptor 1

Indexed keywords

ANIMALS; CATION TRANSPORT PROTEINS; HUMANS; IRON; MONONUCLEAR PHAGOCYTE SYSTEM; RECEPTORS, TRANSFERRIN;

EID: 84894184816     PISSN: 17474086     EISSN: 17474094     Source Type: Journal    
DOI: 10.1586/17474086.2013.814840     Document Type: Review

References (82)

1. Knutson M, Wessling-Resnick M. Iron metabolism in the reticuloendothelial system. Crit. Rev. Biochem. Mol. Biol. 38(1), 61-88 (2003).
2. Kong WN. Iron metabolism in the mononuclear phagocyte system. Prog. Nat. Sci. 18, 1197-1202 (2008).
3. White C, Yuan X, Schmidt PJ et al. HRG1 Is essential for heme transport from the phagolysosome of macrophages during erythrophagocytosis. Cell Metab. 17(2), 261-270 (2013).
4. Kristiansen M, Graversen JH, Jacobsen C et al. Identification of the haemoglobin scavenger receptor. Nature 409(6817), 198-201 (2001).
5. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Ann. Rev. Pharmacol. Toxicol. 37, 517-554 (1997).
6. Kovtunovych G, Eckhaus MA, Ghosh MC, Ollivierre-Wilson H, Rouault TA. Dysfunction of the heme recycling system in heme oxygenase 1-deficient mice: effects on macrophage viability and tissue iron distribution. Blood 116(26), 6054-6062 (2010).
7. Reichard JF, Motz GT, Puga A. Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1. Nucleic Acids Res. 35(21), 7074-7086 (2007).
8. Marro S, Chiabrando D, Messana E et al. Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position-7007 of the FPN1 promoter. Haematologica 95(8), 1261-1268 (2010).
9. Rushworth SA, Chen XL, Mackman N, Ogborne RM, O'connell MA. Lipopolysaccharide-induced heme oxygenase-1 expression in human monocytic cells is mediated via Nrf2 and protein kinase C. J. Immunol. 175(7), 4408-4415 (2005).
10. Hung CC, Liu X, Kwon MY, Kang YH, Chung SW, Perrella MA. Regulation of heme oxygenase-1 gene by peptidoglycan involves the interaction of Elk-1 and C/EBPalpha to increase expression. Am. J. Physiol. Lung Cell Mol. Physiol. 298(6), L870-L879 (2010).
11. Pae HO, Kim EC, Chung HT. Integrative survival response evoked by heme oxygenase-1 and heme metabolites. J. Clin. Biochem. Nutr. 42(3), 197-203 (2008).
12. Chung SW, Chen YH, Perrella MA. Role of Ets-2 in the regulation of heme oxygenase-1 by endotoxin. J. Biol. Chem.280(6), 4578-4584 (2005).
13. Chung SW, Chen YH, Yet SF, Layne MD, Perrella MA. Endotoxin-induced downregulation of Elk-3 facilitates heme oxygenase-1 induction in macrophages. J. Immunol. 176(4), 2414-2420 (2006).
14. Wang J, Pantopoulos K. Regulation of cellular iron metabolism. Biochem. J. 434(3), 365-381 (2011).
15. Wardrop SL, Richardson DR. Interferongamma and lipopolysaccharide regulate the expression of Nramp2 and increase the uptake of iron from low relative molecular mass complexes by macrophages. Eur. J. Biochem. 267(22), 6586-6593 (2000).
16. Weiss G, Goossen B, Doppler W et al. Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway. EMBO J. 12(9), 3651-3657 (1993).
17. Drapier JC, Hirling H, Wietzerbin J, Kaldy P, Kuhn LC. Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J. 12(9), 3643-3649 (1993).
18. Kim S, Ponka P. Control of transferrin receptor expression via nitric oxide-mediated modulation of iron-regulatory protein 2. J. Biol. Chem. 274(46), 33035-33042 (1999).
19. Wang J, Chen G, Pantopoulos K. Nitric oxide inhibits the degradation of IRP2. Mol. Cell. Biol. 25(4), 1347-1353 (2005).
20. Richardson DR, Neumannova V, Nagy E, Ponka P. The effect of redox-related species of nitrogen monoxide on transferrin and iron uptake and cellular proliferation of erythroleukemia (K562) cells. Blood 86(8), 3211-3219 (1995).
21. Schroder H. No nitric oxide for HO-1 from sodium nitroprusside. Mol. Pharmacol. 69(5), 1507-1509 (2006).
22. Wang J, Fillebeen C, Chen G, Andriopoulos B, Pantopoulos K. Sodium nitroprusside promotes IRP2 degradation via an increase in intracellular iron and in the absence of S nitrosylation at C178. Mol. Cell. Biol. 26(5), 1948-1954 (2006).
23. Kim S, Ponka P. Effects of interferongamma and lipopolysaccharide on macrophage iron metabolism are mediated by nitric oxide-induced degradation of iron regulatory protein 2. J. Biol. Chem. 275(9), 6220-6226 (2000).
24. Recalcati S, Taramelli D, Conte D, Cairo G. Nitric oxide-mediated induction of ferritin synthesis in J774 macrophages by inflammatory cytokines: role of selective iron regulatory protein-2 downregulation. Blood 91(3), 1059-1066 (1998).
25. Pantopoulos K, Hentze MW. Nitric oxide signaling to iron-regulatory protein: direct control of ferritin mRNA translation and transferrin receptor mRNA stability in transfected fibroblasts. Proc. Natl Acad. Sci. USA 92(5), 1267-1271 (1995).
26. Ludwiczek S, Aigner E, Theurl I, Weiss G. Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 101(10), 4148-4154 (2003).
27. Peracino B, Wagner C, Balest A et al. Function and mechanism of action of Dictyostelium Nramp1 (Slc11a1) in bacterial infection. Traffic 7(1), 22-38 (2006).
28. Goswami T, Bhattacharjee A, Babal P et al. Natural-resistance-associated macrophage protein 1 is an H+/bivalent cation antiporter. Biochem. J. 354(Pt 3), 511-519 (2001).
29. Soe-Lin S, Apte SS, Andriopoulos B Jr et al. Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo. Proc. Natl Acad. Sci. USA 106(14), 5960-5965 (2009).
30. Jabado N, Canonne-Hergaux F, Gruenheid S, Picard V, Gros P. Iron transporter Nramp2/DMT-1 is associated with the membrane of phagosomes in macrophages and Sertoli cells. Blood 100(7), 2617-2622 (2002).
31. Soe-Lin S, Apte SS, Mikhael MR, Kayembe LK, Nie G, Ponka P. Both Nramp1 and DMT1 are necessary for efficient macrophage iron recycling. Exp. Hematol. 38(8), 609-617 (2010).
32. Kong WN, Zhao SE, Duan XL, Yang Z, Qian ZM, Chang YZ. Decreased DMT1 and increased ferroportin 1 expression is the mechanisms of reduced iron retention in macrophages by erythropoietin in rats. J. Cell. Biochem. 104(2), 629-641 (2008).
33. Hubert N, Hentze MW. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc. Natl Acad. Sci. USA 99(19), 12345-12350 (2002).
34. Martini LA, Tchack L, Wood RJ. Iron treatment downregulates DMT1 and IREG1 mRNA expression in Caco-2 cells. J. Nutr. 132(4), 693-696 (2002).
35. Zoller H, Koch RO, Theurl I et al. Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology 120(6), 1412-1419 (2001).
36. Wardrop SL, Wells C, Ravasi T, Hume DA, Richardson DR. Induction of Nramp2 in activated mouse macrophages is dissociated from regulation of the Nramp1, classical inflammatory genes, and genes involved in iron metabolism. J. Leukoc. Biol. 71(1), 99-106 (2002).
37. Nguyen NB, Callaghan KD, Ghio AJ, Haile DJ, Yang F. Hepcidin expression and iron transport in alveolar macrophages. Am. J. Physiol. Lung Cell Mol. Physiol. 291(3), L417-L425 (2006).
38. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 13(2), 85-94 (2001).
39. Han KY, Kwon TH, Lee TH, Lee SJ, Kim SH, Kim J. Suppressive effects of Lithospermum erythrorhizon extracts on lipopolysaccharide-induced activation of AP-1 and NF-kappaB via mitogen-activated protein kinase pathways in mouse macrophage cells. BMB Rep. 41(4), 328-333 (2008).
40. Lee PL, Gelbart T, West C, Halloran C, Beutler E. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms. Blood Cell. Mol. Dis. 24(2), 199-215 (1998).
41. Pinero DJ, Li N, Hu J, Beard JL, Connor JR. The intracellular location of iron regulatory proteins is altered as a function of iron status in cell cultures and rat brain. J. Nutr. 131(11), 2831-2836 (2001).
42. Delaby C, Pilard N, Hetet G et al. A physiological model to study iron recycling in macrophages. Exp. Cell Res. 310(1), 43-53 (2005).
43. Oliveira L, Drapier JC. Down-regulation of iron regulatory protein 1 gene expression by nitric oxide. Proc. Natl Acad. Sci. USA 97(12), 6550-6555 (2000).
44. Knutson MD, Vafa MR, Haile DJ, Wessling-Resnick M. Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. Blood 102(12), 4191-4197 (2003).
45. Knutson MD, Oukka M, Koss LM, Aydemir F, Wessling-Resnick M. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and downregulated by hepcidin. Proc. Natl Acad. Sci. USA 102(5), 1324-1328 (2005).
46. Zhang Z, Zhang F, An P et al. Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses. Blood 118(7), 1912-1922 (2011).
47. Delaby C, Pilard N, Goncalves AS, Beaumont C, Canonne-Hergaux F. Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin. Blood 106(12), 3979-3984 (2005).
48. Zhang DL, Hughes RM, Ollivierre-Wilson H, Ghosh MC, Rouault TA. A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. Cell Metab. 9(5), 461-473 (2009).
49. Yang F, Wang X, Haile DJ, Piantadosi CA, Ghio AJ. Iron increases expression of iron-export protein MTP1 in lung cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 283(5), L932-L939 (2002).
50. Abboud S, Haile DJ. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J. Biol. Chem. 275(26), 19906-19912 (2000).
51. Liu YQ, Duan XL, Chang YZ, Wang HT, Qian ZM. Molecular analysis of increased iron status in moderately exercised rats. Mol. Cell Biochem. 282(1-2), 117-123 (2006).
52. Wang SM, Fu LJ, Duan XL et al. Role of hepcidin in murine brain iron metabolism. Cell. Mol. Life Sci. 67(1), 123-133 (2010).
53. Guo P, Cui R, Chang YZ et al. Hepcidin, an antimicrobial peptide is downregulated in ceruloplasmin-deficient mice. Peptides 30(2), 262-266 (2009).
54. Viatte L, Lesbordes-Brion JC, Lou DQ et al. Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice. Blood 105(12), 4861-4864 (2005).
55. Nemeth E, Tuttle MS, Powelson J et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306(5704), 2090-2093 (2004).
56. De Domenico I, Ward DM, Langelier C et al. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol. Biol. Cell 18(7), 2569-2578 (2007).
57. De Domenico I, Lo E, Ward DM, Kaplan J. Hepcidin-induced internalization of ferroportin requires binding and cooperative interaction with Jak2. Proc. Natl Acad. Sci. USA. 106(10), 3800-3805 (2009).
58. Ross SL, Tran L, Winters A et al. Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT. Cell Metab. 15(6), 905-917 (2012).
59. Qiao B, Sugianto P, Fung E et al. Hepcidininduced endocytosis of ferroportin is dependent on ferroportin ubiquitination. Cell Metab. 15(6), 918-924 (2012).
60. Yang F, Liu XB, Quinones M, Melby PC, Ghio A, Haile DJ. Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation. J. Biol. Chem. 277(42), 39786-39791 (2002).
61. Liu XB, Nguyen NB, Marquess KD, Yang F, Haile DJ. Regulation of hepcidin and ferroportin expression by lipopolysaccharide in splenic macrophages. Blood Cells Mol. Dis. 35(1), 47-56 (2005).
62. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101(7), 2461-2463 (2003).
63. Theurl I, Theurl M, Seifert M et al. Autocrine formation of hepcidin induces iron retention in human monocytes. Blood 111(4), 2392-2399 (2008).
64. Peyssonnaux C, Zinkernagel AS, Datta V, Lauth X, Johnson RS, Nizet V. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 107(9), 3727-3732 (2006).
65. Sow FB, Florence WC, Satoskar AR, Schlesinger LS, Zwilling BS, Lafuse WP. Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. J. Leukoc. Biol. 82(4), 934-945 (2007).
66. Babitt JL, Lin HY. The molecular pathogenesis of hereditary hemochromatosis. Semin. Liver. Dis. 31(3), 280-292 (2011).
67. Santos PC, Dinardo CL, Cancado RD, Schettert IT, Krieger JE, Pereira AC. Non-HFE hemochromatosis. Rev. Bras. Hematol. Hemoter. 34(4), 311-316 (2012).
68. Wallace DF, Pedersen P, Dixon JL et al. Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis. Blood 100(2), 692-694 (2002).
69. Schimanski LM, Drakesmith H, Merryweather-Clarke AT et al. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood 105(10), 4096-4102 (2005).
70. De Domenico I, Ward DM, Nemeth E et al. The molecular basis of ferroportinlinked hemochromatosis. Proc. Natl Acad. Sci. USA 102(25), 8955-8960 (2005).
71. Mayr R, Janecke AR, Schranz M et al. Ferroportin disease: a systematic metaanalysis of clinical and molecular findings. J. Hepatol. 53(5), 941-949 (2010).
72. Fernandes A, Preza GC, Phung Y et al. The molecular basis of hepcidin-resistant hereditary hemochromatosis. Blood 114(2), 437-443 (2009).
73. Sham RL, Phatak PD, West C, Lee P, Andrews C, Beutler E. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features. Blood Cells Mol. Dis. 34(2), 157-161 (2005).
74. Roetto A, Papanikolaou G, Politou M et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 33(1), 21-22 (2003).
75. Lin L, Goldberg YP, Ganz T. Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood 106(8), 2884-2889 (2005).
76. Spivak JL. Iron and the anemia of chronic disease. Oncology (Williston Park) 16(9 Suppl. 10), 25-33 (2002).
77. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100(10), 3776-3781 (2002).
78. Means RT Jr. The anaemia of infection. Baillieres Best Pract. Res. Clin. Haematol. 13(2), 151-162 (2000).
79. Ferring-Appel D, Hentze MW, Galy B. Cell-autonomous and systemic contextdependent functions of iron regulatory protein 2 in mammalian iron metabolism. Blood 113(3), 679-687 (2009).
80. Finch CA, Deubelbeiss K, Cook JD et al. Ferrokinetics in man. Medicine 49(1), 17-53 (1970).
81. Sizemore DJ, Bassett ML. Monocyte transferrin-iron uptake in hereditary hemochromatosis. Am. J. Hematol. 16(4), 347-354 (1984).
82. Recalcati S, Locati M, Marini A et al. Differential regulation of iron homeostasis during human macrophage polarized activation. Eur. J. Immunol. 40(3), 824-835 (2010).